Ultimate Protection Against Hepatitis B | For Adults with Renal Failure, ESRD, Dialysis

Protect your health with Recombivax HB Adult Dialysis Hepatitis B Vaccine (Recombinant) 40 mcg/1 mL Single-dose Vial by Merck—the leading FDA-approved, CDC-recommended hepatitis B vaccine designed specifically for adults undergoing hemodialysis and living with chronic kidney disease (CKD) or end-stage renal disease (ESRD).

This high-potency hepatitis B vaccine delivers strong immunity for high-risk populations, helping prevent hepatitis B virus (HBV) infection, liver disease, cirrhosis, and hepatocellular carcinoma. Recombivax HB is the top choice for vaccination in the dialysis center and hospital settings, trusted by healthcare professionals and pharmacists nationwide.

Key Features:

• High Dose Formula: 40 mcg/1 mL single-dose vial—optimized for adult dialysis patients and immunocompromised individuals.
• Recombinant DNA Technology: Provides safe, highly effective HBV surface antigen for strong, lasting immunity.
• Single-Dose Convenience: Easy, accurate dosing; reduces waste and cross-contamination risk.
• CDC & ACIP Recommended: Meets the latest guidelines for adult hepatitis B immunization, ESRD treatment, and infection control.
• Leading Manufacturer: Produced by Merck—global leader in vaccine technology, quality, and safety.

Top Health Benefits:

• Prevents Hepatitis B Infection: Protects against chronic and acute HBV, a major cause of liver failure, liver cancer, and death.
• Essential for Dialysis Patients: Kidney failure and dialysis increase HBV risk—get protected now!
• Boosts Immune Response: Especially formulated for patients with weaker immune systems.
• Reduces Transmission Risk: Reduces spread of hepatitis B in healthcare, dialysis clinics, and community settings.

Who Should Get the Recombivax HB Dialysis Vaccine?

• Adults (18+) starting or currently on hemodialysis or peritoneal dialysis
• Individuals with chronic kidney disease (CKD stages 4-5)
• Patients awaiting kidney transplant
• Healthcare workers, nursing home staff, and other at-risk adults

How to Use:

• Dosage & Administration: Inject intramuscularly (IM) as recommended (typically 3-dose series at 0, 1, and 6 months or as directed)
• Professional Use Only: For use by physicians, nurses, and healthcare professionals

Ingredients & Safety:

• Contains recombinant hepatitis B surface antigen (HBsAg)
• Preservative-free formula
• No human blood products or live virus
• Minimal side effects—commonly mild soreness at injection site
• Contraindications: Allergic reaction to yeast or prior dose

Why Choose Recombivax HB by Merck?

• #1 prescribed hepatitis B vaccine in the USA for adults on dialysis
• Backed by decades of clinical research and global health experience
• Meets all US regulatory and quality standards for vaccine safety

Order Now for Fast Shipping, Fresh Stock, and Unbeatable Pricing!